|
|
Avandia - Newsfeeds
-
-
Actos (pioglitazone) a pill that is used to treat adult onset diabetes, is also found to prevent the development of Type 2 diabetes in high-risk people. The results could help tens of millions of pre-diabetics in the world, including 40 million Americans ...
-
-
THURSDAY, Sept. 23 (HealthDay News) -- In response to major concerns about heart risks, U.S. health officials on Thursday severely restricted use of the diabetes drug rosiglitazone (Avandia) to patients with type 2 diabetes who cannot control their disease ...
-
-
Limit alcohol while taking this medication because it can increase the risk of your blood sugar getting too low (hypoglycemia). During times of stress, such as fever, infection, injury or surgery, it may be more difficult to control your blood sugar ...
-
-
WEDNESDAY, July 14 (HealthDay News) -- The controversial diabetes drug Avandia does raise the risk of heart attack more than other medications of its kind but should stay on the market with tightened controls, a U.S. government advisory panel recommended ...
-
-
FRIDAY, July 9 (HealthDay News) -- With a crucial recommendation on the fate of the controversial diabetes drug Avandia due next week, U.S. health officials seem to be gearing up for tough scrutiny over the drug's future. A U.S. Food and Drug ...
-
-
MONDAY, Nov. 24 (HealthDay News) -- The widely used diabetes drug Avandia -- already controversial because of cardiovascular side effects -- may be riskier than Actos, another drug in the same class, researchers reported Monday. The risk of heart failure ...
-
-
BATON ROUGE, La. (AP) -- Louisiana Attorney General Buddy Caldwell is suing British drug maker GlaxoSmithKline PLC, claiming the company hid harmful side effects of the diabetes drug Avandia. The lawsuit, filed in civil district court this week, accuses ...
-
-
REDWOOD CITY, CA and WASHINGTON, DC--(Marketwire - 10/01/10) - In an exclusive interview to be aired on the October 3 "BioCentury This Week" TV show, FDA's Joshua Sharfstein, the agency's Principal Deputy Director, explodes some of the myths about drug ...
-
-
The BBC said that Avandia, also known as rosiglitazone, was suspended in Europe but is still available in the US and Canada. Avandia is the brand name of the diabetic drug rosiglitazone, which was banned in 2010 after the European Medicines Agency ...
-
-
The use of a similar drug, rosiglitazone, sold as Avandia, has been suspended in Europe and restricted in the U.S. after studies found it increased the risk of heart disease deaths among diabetics. A review of 16 studies involving 810,000 patients ...
-
-
The American Diabetes Association applauds the Equal Employment Opportunity Commission for its publication of reasonable and clear regulations protecting the rights of people with diabetes and other disabilities in the workplace. The regulations implement ...
-
-
The study was published in the peer-reviewed British Medical Journal . The news reports accurately reflected the findings of this review. This was a systematic review and meta-analysis of observational studies. The aim of the research was to compare the ...
-
-
When Takeda launched a switch campaign in 2010 to capitalize on the issues with Avandia (GlaxoSmithKline’s Oral Type 2 Diabetes Medication), social media response was hostile. They believe ACTOS has not truly differentiated itself from Avandia ...
-
-
GSK could now face the prospect of a Philadelphia state court jury in defending a growing wave of lawsuits over drugs such as Avandia, a diabetes treatment, and Lamictal, an anti-seizure drug. Many of the plaintiffs in those cases hail from other states ...
-
-
There is another glitazone on the market in the U.S., rosiglitazone or Avandia. Since the medication first hit the market in the 1990s, I always preferred Actos for one reason. Avandia was known to be associated with a small bump in LDL cholesterol levels.
-
-
Lifestyle changes and dieting reduce it by about 58 percent. Rosiglitazone, sold under the brand-name Avandia, has been shown to reduce progression by 62 percent, but because of cardiac concerns, the Food and Drug Administration has restricted use of the ...
-
-
Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver. Results of this ...
-
-
As early as 2003, researchers looked at the possibility of whether hormone-treated foods may bring on early puberty ing girls (http://envirocancer.cornell.edu/Factsheet/Diet/fs37.ho rmones.cfm). In 2007, scientists were looking at plastics and insecticides ...
-
-
Tethys Bioscience, Inc., a privately held cardiometabolic diagnostics company, and the United States Air Force have established a collaboration to study the impact of the PreDx® Diabetes Risk Score on behavioral change, the key component in reducing the ...
-
-
Multiple-year follow-up Dr. DeFronzo led the trial of pioglitazone, which is marketed as Actos ® by Takeda Pharmaceutical Co. Ltd. The Japanese company provided an independent investigator grant to Dr. DeFronzo to conduct the ACT Now study. Some patients ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
Previous
...
4
5
6
7
8
9
10
11
12
13
14
...
Next
|
|